Home Stock

Stock Research: JCR Pharmaceuticals

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

JCR Pharmaceuticals

TYO:4552 JP3701000006
1
  • Value
    51
  • Growth
    52
  • Safety
    Safety
    10
  • Combined
    20
  • Sentiment
    1
  • 360° View
    360° View
    1
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business and the medical and research equipment business. The company operates in two segments: the Pharmaceutical segment (research, production, purchase, and sale of medical drugs and pharmaceutical raw materials) and the Medical and Research Equipment segment (purchase and sale of medical and research equipment). It primarily operates in Japan. In the last fiscal year, the company had 987 employees, a market cap of $598 million, profits of $145 million, and revenue of $221 million.

more
Strongest Rank Sentiment
Weakest Rank Dividend Yield
Country Japan
Industry Pharmaceuticals
Size Small
Website jcrpharm.co.jp
Index
JCR Pharmaceuticals stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 74 34 25
Growth
52 4 27 73
Safety
Safety
10 41 57 28
Sentiment
1 1 57 31
360° View
360° View
1 4 36 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
7 28 41 44
Opinions Change
23 21 69 50
Pro Holdings
n/a 1 84 30
Market Pulse
9 13 33 51
Sentiment
1 1 57 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 74 34 25
Growth
52 4 27 73
Safety Safety
10 41 57 28
Combined
20 18 31 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
43 54 32 20
Price vs. Earnings (P/E)
24 53 49 47
Price vs. Book (P/B)
52 69 38 16
Dividend Yield
85 84 51 34
Value
51 74 34 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
5 6 6 4
Profit Growth
83 9 85 91
Capital Growth
46 7 51 94
Stock Returns
63 6 11 39
Growth
52 4 27 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
18 25 25 20
Refinancing
31 41 49 17
Liquidity
8 67 84 82
Safety Safety
10 41 57 28

Similar Stocks

Discover high‑ranked alternatives to JCR Pharmaceuticals and broaden your portfolio horizons.

Mitsubishi HC Capital

TYO:8593
Country: Japan
Industry: Specialized Finance
Size: X-Large
Full Stock Analysis

BML

TYO:4694
Country: Japan
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Fuji

TYO:6134
Country: Japan
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Systena

TYO:2317
Country: Japan
Industry: Application Software
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews